Dr. Kase is Emeritus Professor of Neurology at Boston University School of Medicine. Born in Buenos Aires, Argentina, Dr. Carlos Kase earned his MD degree in Santiago, Chile, from the Catholic University of Chile in May 1967. He pursued further training in Neurology and Vascular Neurology at Massachusetts General Hospital in Boston from 1972-1973, and 1977-1978. Dr. Kase is board-certified by the American Board of Psychiatry and Neurology in Neurology (1980) and also board-certified in the subspecialty of Vascular Neurology (2005).
Dr. Kase joined the Department of Neurology at Boston University School of Medicine in 1984 and is Neurologist-in-Chief, Boston Medical Center. Prior to this, he joined Dr. J.P. Mohr in forming the Neurology Department at the University of South Alabama in Mobile, Alabama in 1978.
Dr. Kase’s professional and research interests are in cerebrovascular diseases, with a special interest in intracerebral hemorrhage, carotid artery disease and lacunar infarctions. He has been actively involved in performing clinical studies and clinico-pathologic correlations in intracerebral hemorrhage and cerebral infarction. His research activities have included participation in multicenter NIH-sponsored studies such as the Stroke Data Bank (NINCDS), the Warfarin Aspirin Recurrent Stroke Study (WARSS), the Warfarin vs. Aspirin for Symptomatic Intracranial Disease (WASID) Study, the Secondary Prevention of Small Subcortical Strokes (SPS3) study, and the Insulin Resistance Intervention after Stroke (IRIS) trial, as well as in a number of therapeutic clinical trials. In addition, Dr. Kase has participated in the Framingham Study since 1984, where he has led a number of important epidemiological studies on risk factors in stroke.
Dr. Kase has received numerous distinguished honors for his work in cerebrovascular disease, including Honorary Membership to the Spanish Society of Neurology and the Mexican Association of Cerebrovascular Disease. In 2001, he received the C. Miller Fisher Award for Excellence in Stroke, awarded by the American Stroke Association, Massachusetts Affiliate. In 2002 he was awarded the title of Doctor Honoris Causa from the Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Dr. Kase was recognized as a “Top Doctor” in Neurology by Boston Magazine in 2009, 2010, 2011, 2012 and by U.S. News and World Report in 2011.
- Pontificia Universidad Católica de Chile, MD
- Pontificia Universidad Católica de Chile, BS
- Published on 3/10/2020
Lun R, Yogendrakumar V, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Silva Y, Dzialowski I, Kobayashi A, Boulanger JM, Gubitz G, Srivastava P, Roy J, Kase CS, Bhatia R, Hill MD, Dowlatshahi D. Calculation of Prognostic Scores, Using Delayed Imaging, Outperforms Baseline Assessments in Acute Intracerebral Hemorrhage. Stroke. 2020 Apr; 51(4):1107-1110. PMID: 32151235.
- Published on 2/6/2020
Yogendrakumar V, Ramsay T, Fergusson DA, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Silva Y, Dzialowski I, Kobayashi A, Boulanger JM, Gubitz G, Srivastava P, Roy J, Kase CS, Bhatia R, Hill MD, Goldstein JN, Dowlatshahi D. Redefining Hematoma Expansion With the Inclusion of Intraventricular Hemorrhage Growth. Stroke. 2020 Apr; 51(4):1120-1127. PMID: 32078498.
- Published on 8/12/2019
Jeanneret V, Beach PA, Kase CS. Ocular Dipping in Anoxic Brain Injury. JAMA Neurol. 2019 Aug 12. PMID: 31403654.
- Published on 8/1/2019
Yogendrakumar V, Ramsay T, Fergusson DA, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Silva Blas Y, Dzialowski I, Kobayashi A, Boulanger JM, Lum C, Gubitz G, Srivastava P, Roy J, Kase CS, Bhatia R, Hill MD, Selim M, Dowlatshahi D. Independent Validation of the Hematoma Expansion Prediction Score: A Non-contrast Score Equivalent in Accuracy to the Spot Sign. Neurocrit Care. 2019 08; 31(1):1-8. PMID: 31123995.
- Published on 8/1/2019
Yogendrakumar V, Ramsay T, Fergusson D, Demchuk AM, Aviv RI, Rodriguez-Luna D, Molina CA, Silva Y, Dzialowski I, Kobayashi A, Boulanger JM, Lum C, Gubitz G, Srivastava P, Roy J, Kase CS, Bhatia R, Hill MD, Warren AD, Anderson CD, Gurol ME, Greenberg SM, Viswanathan A, Rosand J, Goldstein JN, Dowlatshahi D. New and expanding ventricular hemorrhage predicts poor outcome in acute intracerebral hemorrhage. Neurology. 2019 08 27; 93(9):e879-e888. PMID: 31371565.
- Published on 7/28/2019
Beach PA, Dhakar MB, Kase CS. Sudden Onset Fluent Aphasia: Stroke or Seizure? Neurohospitalist. 2020 Apr; 10(2):121-126. PMID: 32373276.
- Published on 5/14/2019
Aparicio HJ, Himali JJ, Satizabal CL, Pase MP, Romero JR, Kase CS, Beiser AS, Seshadri S. Temporal Trends in Ischemic Stroke Incidence in Younger Adults in the Framingham Study. Stroke. 2019 06; 50(6):1558-1560. PMID: 31084341.
- Published on 5/7/2019
Micieli JA, Newman NJ, Kase CS, Biousse V. Teaching Video NeuroImages: Opsoclonus in anti-DPPX encephalitis. Neurology. 2019 05 07; 92(19):e2298. PMID: 31061220.
- Published on 4/10/2019
Rist PM, Buring JE, Ridker PM, Kase CS, Kurth T, Rexrode KM. Lipid levels and the risk of hemorrhagic stroke among women. Neurology. 2019 05 07; 92(19):e2286-e2294. PMID: 30971484.
- Published on 4/3/2019
Ziai WC, McBee N, Lane K, Lees KR, Dawson J, Vespa P, Thompson RE, Mendelow AD, Kase CS, Carhuapoma JR, Thompson CB, Mayo SW, Reilly P, Janis S, Anderson CS, Harrigan MR, Camarata PJ, Caron JL, Zuccarello M, Awad IA, Hanley DF. A randomized 500-subject open-label phase 3 clinical trial of minimally invasive surgery plus alteplase in intracerebral hemorrhage evacuation (MISTIE III). Int J Stroke. 2019 07; 14(5):548-554. PMID: 30943878.
View 198 more publications: View full profile at BUMC